Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$13.6 - $17.06 $18,142 - $22,758
1,334 Added 53.62%
3,822 $55,000
Q1 2024

May 15, 2024

BUY
$13.68 - $17.6 $28,618 - $36,819
2,092 Added 528.28%
2,488 $43,000
Q4 2023

Feb 13, 2024

SELL
$14.87 - $17.56 $773 - $913
-52 Reduced 11.61%
396 $6,000
Q3 2023

Nov 14, 2023

SELL
$16.8 - $20.99 $37,833 - $47,269
-2,252 Reduced 83.41%
448 $7,000
Q2 2023

Aug 14, 2023

SELL
$16.03 - $20.07 $92,332 - $115,603
-5,760 Reduced 68.09%
2,700 $54,000
Q1 2023

May 09, 2023

BUY
$15.67 - $18.91 $41,196 - $49,714
2,629 Added 45.09%
8,460 $147,000
Q4 2022

Feb 10, 2023

BUY
$13.5 - $17.14 $2,241 - $2,845
166 Added 2.93%
5,831 $90,000
Q3 2022

Nov 10, 2022

BUY
$14.23 - $17.76 $80,612 - $100,610
5,665 New
5,665 $87,000

Others Institutions Holding BLCO

About Bausch & Lomb Corp


  • Ticker BLCO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 350,000,000
  • Market Cap $6.84B
  • Description
  • Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...
More about BLCO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.